Education Library

Gregg Stone, MD, reviews available data—from PROTECT II through PROTECT IV—for use of mechanical circulatory support during high-risk PCI.

Rajiv Tayal, MD, reviews best practices for large-bore access in this virtual fellows course.

A. Reshad Garan, MD, discusses the importance of determining etiology and predicting risk in patients with acute decompensated heart failure-related cardiogenic shock.

Hady Lichaa, MD, discusses an innovative single-access dry-closure technique with iliac artery angioplasty through the ipsilateral sheath.

Benedikt Schrage, MD, discusses his paper examining how enrollment criteria in RCTs apply to the real-world cardiogenic shock patient population.

David Wohns, MD, presents the Spectrum Health heart team process and reviews best practices and tools for heart team implementation.

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

This live case from Kate Kearney, MD and William Lombardi, MD, highlights Impella-supported complex PCI and complete revascularization in a patient with severe LV dysfunction.

This virtual fellows course covers topics ranging from complete revascularization in high-risk PCI to best practices for large bore access and management of cardiogenic shock.

Timothy Smith, MD, discusses the importance of the cardiovascular ICU and device management for patients with cardiogenic shock supported with the Impella® heart pump.

This Impella skills video demonstrates the mattress suture technique used during insertion of the Impella RP® heart pump.

This Impella skills video demonstrates how to change the femoral access site dressing in the ICU.

View an animation depicting the primary steps for anterior direct insertion of Impella 5.5 with SmartAssist.

This FAQ addresses thrombus formation and anticoagulation for blood-contacting medical devices, such as the Impella® heart pump.

A study of 21,848 non-emergent, high-risk patients who underwent PCI with PVADs, including Impella® heart pumps, demonstrates the PVAD patients had a lower rate of mortality and complications than patients who underwent PCI with IABPs.